Search
Clinical Trial
Nemtabrutinib and Pembrolizumab in Patients with Richter Transformation: A Phase II Study.
… Patients with Richter Transformation: A Phase II Study. II Cortese, Matthew J This phase II trial tests how well nemtabrutinib in …
Clinical Trial
A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)
… Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011) III Cortese, Matthew J The goal of this study is to evaluate nemtabrutinib …
Clinical Trial
A Randomized, Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma …
… With GCB Subtype of Diffuse Large B-cell Lymphoma … II Cortese, Matthew J Researchers are looking for ways to treat germinal …
News
Tandem 2025: Roswell Park Team Creates Predictive Model to Inform Care of Lymphoma Patients
… Adults undergoing Stem cell transplantation) Consortium.” Matthew Cortese, MD, MPH , Assistant Professor of Oncology, … on the work. Marco Davila, MD, PhD Theresa Hahn, PhD Matthew Cortese, MD, MPH Showkat Hamid, MD ### From the … Adults undergoing Stem cell transplantation) Consortium.” Matthew Cortese, MD, MPH , Assistant Professor of Oncology, …
Hematology and Medical Oncology Program Faculty
… Hematologic Oncology Gurkamal Chatta, MD Medical Oncology Matthew Cortese, MD, MPH Medical Oncology and Hematology …
Tumor Immunology & Immunotherapy Program Members
… Director, Neuro-Oncology Lab Department of Neurosurgery Matthew Cortese, MD, MPH Assistant Professor of Oncology …
Updates in Hematologic Malignancies and Related Supportive Care
… Speakers Renier Brentjens, MD, PhD Hematologic Oncology Matthew Cortese, MD, MPH Medical Oncology and Hematology …
Roswell Park at American Society of Hematology 2024
… Chair in Cancer Medicine Chair, Department of Medicine Matthew Cortese, MD, MPH Assistant Professor of Oncology … to meet with? Brian Betts, MD Renier Brentjens, MD, PhD Matthew Cortese, MD, MPH Marco Davila, MD, PhD Mark Frattini, … Wright is first/presenting author, with senior authors Matthew Cortese, MD, MPH , and Spencer Rosario, PhD , on …
News
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
… oral abstracts On Saturday, Dec. 7, at 10:45 a.m., Matthew Cortese, MD, MPH , will present abstract 78, Multiomic … Grand Hyatt San Diego). On Sunday, Dec. 8, at 10 a.m., Dr. Cortese will present abstract 525, Clinical Outcomes of … oral abstracts On Saturday, Dec. 7, at 10:45 a.m., Matthew Cortese, MD, MPH , will present abstract 78, …
Blog Post
Nodular lymphocyte-predominant Hodgkin lymphoma: Leah's story
… a week, Leah met with medical oncologist and hematologist Matthew Cortese, MD, MPH , who specializes in treating patients with lymphoma at Roswell Park. “Dr. Cortese was upfront, stating that I had a tough road ahead … a week, Leah met with medical oncologist and hematologist Matthew Cortese, MD, MPH , who specializes in treating …